ESP-31015
ESP-31015 (ETC-1001) is an orally active and non-fibrate based PPARα agonists. ESP-31015 demonstrates significant lipid-regulating effects in the obese Zucker rat model. ESP-31015 can be used in cardiovascular disease research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 413624-55-2
- Fòrmula: C17H34O3
- Peso molecular:286.45
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
IC50 & Target
[1]|
PPARα |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | IC50 |
1.5 μM
Compound: 39
|
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
|
[PMID: 16392818] |
| Hepatocyte | IC50 |
4 μM
Compound: 14c
|
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
|
[PMID: 15537362] |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female obese Zucker fatty rats model[1]
-
Dosage:100 mg/kg
-
Administration:Oral administration (p.o.), once daily for 2 weeks
-
Result:Showed a 34.6% increase in serum HDL-cholesterol and a 71% reduction in serum triglycerides.
Chemical Information
-
No. CAS 413624-55-2
-
Peso molecular 286.45
-
Fòrmula C17H34O3
-
SMILES
OCC(C)(C)CCCCC(CCCCC(C)(C)CO)=O
-
Synonyms
ETC-1001
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)